Skip to content
Disclosery

Capital Research Global Investors: BIO position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Capital Research Global Investors on BIO, newest first. How the timeline and the estimate are built.

Capital Research Global Investors held 443,483 BIO shares at 2026-06-30 per its 13F-HR filed 2026-08-12.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 443,483 shares
    Change vs previous 13F +57,904 shares

    0.02% of the 13F portfolio, value $130,211,044.

    13F-HR 0001422848-26-000094 filed by Capital Research Global Investors
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 385,579 shares
    Change vs previous 13F -108,893 shares

    0.02% of the 13F portfolio, value $107,480,146.

    13F-HR 0001422848-26-000041 filed by Capital Research Global Investors
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 494,472 shares
    Change vs previous 13F +76,117 shares

    0.03% of the 13F portfolio, value $149,820,071.

    13F-HR 0001422848-26-000005 filed by Capital Research Global Investors
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 418,355 shares
    Change vs previous 13F not available

    0.02% of the 13F portfolio, value $117,302,558.

    13F-HR 0001422848-25-000223 filed by Capital Research Global Investors
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).